D.E. Shaw & Co’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$230M Sell
848,200
-417,200
-33% -$124M 0.14% 162
2025
Q4
$418M Buy
1,265,400
+808,000
+177% +$274M 0.23% 86
2025
Q3
$158M Buy
457,400
+183,300
+67% +$55.4M 0.09% 249
2025
Q2
$85.5M Buy
+274,100
New +$105M 0.06% 371
2025
Q1
Sell
-40,000
Closed -$20.2M 4774
2024
Q4
$20.2M Sell
40,000
-18,100
-31% -$10.3M 0.01% 1028
2024
Q3
$34M Buy
58,100
+15,900
+38% +$8.99M 0.03% 698
2024
Q2
$21.5M Sell
42,200
-17,800
-30% -$8.72M 0.02% 856
2024
Q1
$29.7M Sell
60,000
-294,300
-83% -$150M 0.03% 695
2023
Q4
$187M Buy
354,300
+137,500
+63% +$73.3M 0.16% 136
2023
Q3
$109M Sell
216,800
-13,200
-6% -$6.5M 0.11% 200
2023
Q2
$111M Buy
230,000
+70,000
+44% +$34.2M 0.11% 204
2023
Q1
$75.6M Sell
160,000
-103,500
-39% -$49.9M 0.08% 298
2022
Q4
$140M Buy
263,500
+10,000
+4% +$5.3M 0.15% 135
2022
Q3
$128M Buy
253,500
+79,000
+45% +$41.5M 0.15% 115
2022
Q2
$89.6M Buy
174,500
+119,400
+217% +$60M 0.11% 216
2022
Q1
$28.1M Sell
55,100
-124,400
-69% -$60M 0.03% 820
2021
Q4
$90.1M Buy
179,500
+177,000
+7,080% +$80.1M 0.07% 313
2021
Q3
$977K Sell
2,500
-134,400
-98% -$55.7M ﹤0.01% 3620
2021
Q2
$54.8M Buy
136,900
+79,900
+140% +$31.9M 0.05% 493
2021
Q1
$21.2M Sell
57,000
-6,600
-10% -$2.29M 0.02% 893
2020
Q4
$22.3M Buy
63,600
+35,000
+122% +$11.7M 0.02% 898
2020
Q3
$8.92M Sell
28,600
-144,600
-83% -$44.4M 0.01% 1314
2020
Q2
$51.1M Buy
173,200
+74,500
+75% +$21.3M 0.06% 351
2020
Q1
$24.6M Sell
98,700
-181,800
-65% -$50M 0.04% 525
2019
Q4
$82.5M Buy
280,500
+121,700
+77% +$31.8M 0.09% 251
2019
Q3
$34.5M Buy
158,800
+99,700
+169% +$24.1M 0.04% 525
2019
Q2
$14.4M Buy
59,100
+34,400
+139% +$8.27M 0.02% 929
2019
Q1
$6.11M Sell
24,700
-5,300
-18% -$1.35M 0.01% 1415
2018
Q4
$7.47M Sell
30,000
-56,400
-65% -$14.9M 0.01% 1274
2018
Q3
$23M Sell
86,400
-400
-0.5% -$104K 0.03% 704
2018
Q2
$21.3M Buy
+86,800
New +$20.8M 0.03% 694
2018
Q1
Sell
-11,100
Closed -$2.45M 3787
2017
Q4
$2.45M Sell
11,100
-105,900
-91% -$22.4M ﹤0.01% 1992
2017
Q3
$22.9M Sell
117,000
-7,300
-6% -$1.41M 0.04% 556
2017
Q2
$23M Buy
124,300
+20,000
+19% +$3.51M 0.04% 539
2017
Q1
$17.1M Sell
104,300
-60,100
-37% -$9.84M 0.03% 650
2016
Q4
$26.3M Buy
164,400
+79,100
+93% +$11.8M 0.04% 515
2016
Q3
$11.9M Sell
85,300
-5,600
-6% -$784K 0.02% 797
2016
Q2
$12.8M Buy
90,900
+84,300
+1,277% +$11.2M 0.02% 754
2016
Q1
$851K Sell
6,600
-30,200
-82% -$3.57M ﹤0.01% 2464
2015
Q4
$4.33M Sell
36,800
-22,800
-38% -$2.66M 0.01% 1514
2015
Q3
$6.91M Sell
59,600
-57,400
-49% -$6.87M 0.01% 1183
2015
Q2
$14.3M Sell
117,000
-16,400
-12% -$1.94M 0.02% 799
2015
Q1
$15.8M Buy
133,400
+34,200
+34% +$3.8M 0.02% 705
2014
Q4
$10M Sell
99,200
-83,900
-46% -$7.95M 0.01% 1109
2014
Q3
$15.8M Buy
183,100
+98,000
+115% +$8.28M 0.02% 819
2014
Q2
$6.96M Sell
85,100
-53,700
-39% -$4.23M 0.01% 1363
2014
Q1
$11.4M Buy
138,800
+27,000
+24% +$2.03M 0.02% 981
2013
Q4
$8.42M Buy
111,800
+51,400
+85% +$3.69M 0.01% 1273
2013
Q3
$4.33M Buy
60,400
+5,300
+10% +$379K 0.01% 1736
2013
Q2
$3.61M Buy
+55,100
New +$3.43M 0.01% 1599

Other funds holding UNH

D.E. Shaw & Co's UNH Position: Q1 2026 in Review

D.E. Shaw & Co increased its UnitedHealth (UNH) stake by 24% in Q1 2026, buying an estimated $67.3M and bringing the position to 1,167,220 shares worth $316M. The position accounts for 0.19% of the portfolio, ranked #99.

D.E. Shaw & Co first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $520M in Q2 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • D.E. Shaw & Co held 1,167,220 shares of UnitedHealth worth $316M as of Q1 2026.
  • D.E. Shaw & Co bought 226,047 UnitedHealth shares in Q1 2026, an estimated $67.3M.
  • UnitedHealth made up 0.19% of D.E. Shaw & Co's portfolio in Q1 2026, its #99 holding.
  • D.E. Shaw & Co first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • D.E. Shaw & Co's UnitedHealth position peaked at $520M in Q2 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.